AQMS Q3 2025 Earnings Significant EPS Miss Highlights Ongoing Challenges for PreRevenue Company ADMA Biologics Q1 2026 Earnings EPS Misses Estimates Amid Stock Downdraft NKSH Q4 2025 Earnings Strong EPS Beat Drives Positive Sentiment RCL Q1 2026 Earnings EPS Surges Past Estimates Yet Stock Slips Xylem Q1 2026 Earnings EPS Slightly Above Estimates Amid Operational Strength WORX Q3 2025 Earnings EPS Loss of 015 Amid Significant Stock Surge